Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "OM-Pharma"

34 News Found

OM Pharma to unveil major real-world evidence breakthrough on Broncho-Vaxom at EAACI
R&D | June 16, 2026

OM Pharma to unveil major real-world evidence breakthrough on Broncho-Vaxom at EAACI

The company will unveil preliminary findings showing that Broncho-Vaxom was associated with a 28–38% reduction in respiratory tract infection rates at 12 months


Evonik and Phathom Pharmaceuticals partner to produce novel acid-blocker vonoprazan
News | October 13, 2022

Evonik and Phathom Pharmaceuticals partner to produce novel acid-blocker vonoprazan

Agreement strengthens Evonik’s track record as leading contract development and manufacturing organization (CDMO)


Industry, regulators and quality experts discuss implementation of Indian Pharmacopoeia 2026
Policy | June 12, 2026

Industry, regulators and quality experts discuss implementation of Indian Pharmacopoeia 2026

Indian Pharmacopoeia Commission hosts scientific conclave to brainstorm on strengthening pharmaceutical quality and compliance


Drug Safety Symposium 2026 to focus on real-world impact of pharmacovigilance
News | May 21, 2026

Drug Safety Symposium 2026 to focus on real-world impact of pharmacovigilance

The event is expected to attract more than 100 senior professionals from pharmaceutical companies, CROs, regulatory agencies, and technology organisations


6th Drug Safety Symposium 2026 to convene over 100 pharmacovigilance leaders
Clinical Trials | May 11, 2026

6th Drug Safety Symposium 2026 to convene over 100 pharmacovigilance leaders

Mumbai event on June 24–25 will spotlight real-world impact of pharmacovigilance beyond AI adoption


Evonik bets €80 million on biotech expansion to power next-gen pharma growth
Biotech | April 23, 2026

Evonik bets €80 million on biotech expansion to power next-gen pharma growth

The investment will bring in cutting-edge downstream fermentation technology, strengthening the company’s contract manufacturing capabilities for drug substances


EMA gives green light to warmer & simpler delivery rules for Wegovy injection
News | April 12, 2026

EMA gives green light to warmer & simpler delivery rules for Wegovy injection

Novo Nordisk continues to position Wegovy as a cornerstone of its obesity treatment portfolio


Merck delivers resilient 2025 performance despite global headwinds
News | March 06, 2026

Merck delivers resilient 2025 performance despite global headwinds

Strong performances in its Life Science, Healthcare and Electronics divisions — particularly Process Solutions, Cardiovascular treatments and Semiconductor Materials — powered the company’s results


IOL Chemicals posts robust Q3 & 9M FY26 results, PBT up 39% YoY
News | February 13, 2026

IOL Chemicals posts robust Q3 & 9M FY26 results, PBT up 39% YoY

Chemicals delivered improved efficiency and optimal capacity utilization, with EBIT rising 37% YoY


BioMed X launches Harvard pilot to connect academia and pharma
R&D | January 14, 2026

BioMed X launches Harvard pilot to connect academia and pharma

Projects selected for advancement will move forward through the Harvard Office of Technology Development’s processes for sponsored research agreements